CARDIOVASCULAR JOURNAL OF AFRICA • Volume 27, No 4, July/August 2016
222
AFRICA
Acquired von Willebrand syndrome in children with aortic
and pulmonary stenosis
Fatih Köksal Binneto
ğ
lu, Kadir Babao
ğ
lu,
Ş
ayegan Güven Filiz, Emine Zengin, Gürkan Altun, Suar Çakı
Kılıç, Nazan Sarper
Abstract
Introduction:
This prospective study was planned to investigate
the frequency and relationship of acquired von Willebrand
syndrome (AVWS) with aortic and pulmonary stenosis in
patients.
Methods:
A total of 84 children, ranging from two to 18 years
of age, were enrolled in this study. Of these, 28 had isolated
aortic stenosis, 32 had isolated pulmonary stenosis and 24
were healthy. Children with aortic and pulmonary stenosis
associated with other congenital heart diseases were excluded.
Children with hypothyroidism, renal or liver disease, malig-
nancy or autoimmune disease were also excluded. Whole-
blood count, blood group, factor VIII level, prothrombin
time (PT), activated partial thromboplastin time (aPTT), von
Willebrand factor antigen (VWF:Ag), ristocetin co-factor
(VWF:RCo), and bleeding time using a platelet-function
analyser (PFA-100) were performed in all patients. All of the
children in the study underwent a detailed physical examina-
tion and echocardiographic evaluation.
Results:
A history of bleeding was positive in 18% of the
aortic stenosis group, 9% of the pulmonary stenosis group,
and 4% of the control group. Seven of 60 (12%) patients had
laboratory findings that implied a diagnosis of AVWS, and
two of these (28%) had a history of bleeding. The frequency
of AVWS was 14% in patients with aortic stenosis and 9% in
those with pulmonary stenosis.
Conclusion:
AVWS is not rare in stenotic obstructive cardiac
diseases. A detailed history of bleeding should be taken from
patients with valvular disease. Even if the history is negative,
whole blood count, PT and aPTT should be performed. If
necessary, PFA-100 closure time and further tests should be
planned for the diagnosis of AVWS.
Keywords:
aortic stenosis, children, pulmonary stenosis, von
Willebrand
Submitted 21/3/15, accepted 7/12/15
Cardiovasc J Afr
2016;
27
: 222–227
www.cvja.co.zaDOI: 10.5830/CVJA-2015-093
Acquired von Willebrand syndrome (AVWS) is a rare clinical
condition characterised by prolonged bleeding time and
decreased levels of factor VIII and von Willebrand factor, as in
congenital von Willebrand disease (VWD). It was first defined
by Simone
et al
. in a seven-year-old boy with systemic lupus
erythematosus.
1
The actual prevalence of AVWS is uncertain.
From 1968 to 1999, a total of 266 cases were reported. The
International Society of Thrombosis and Haemostasis reported
a retrospective analysis of 186 cases in 2000.
2
AVWS is usually associated with underlying diseases such
as lymphoproliferative disorders (48%), cardiovascular diseases
(21%), myeloproliferative disorders (15%), other neoplasms (5%)
and autoimmune diseases (2%).
2
In rare cases, AVWS is also
associated with hypothyroidism, uraemia and certain drugs, such
as valproic acid and ciprofloxacin.
A few studies have reported on the association between
AVWS and aortic stenosis in adults, but there are not enough
studies reporting on the relationship between AVWS and right
ventricular outflow obstruction. In patients with aortic stenosis,
there is a loss of high-molecular-weight multimers, which are
active in coagulation, due to increased shear stress. This situation
can cause bleeding problems after menstruation, circumcision,
dental extraction and congenital heart disease surgery.
No other coagulation tests are routinely used in people with
heart disease, because AVWS has been identified in only a small
number of patients. Therefore, it is of importance to identify
AVWS in children with congenital heart diseases.
1,3-5
In this
study, we aimed to evaluate AVWS in children with aortic and
pulmonary stenosis, and their clinical consequences.
Methods
A total of 84 children, ranging from two to 18 years of age,
were enrolled in this study. Of these, 28 had isolated aortic
Department of Paediatric Cardiology, Çanakkale Onsekiz
Mart University, Çanakkale, Turkey
Fatih Köksal Binneto
ğ
lu, MD,
koksaldr@yahoo.comDepartment of Paediatric Cardiology, Kocaeli University
Medical Faculty, Kocaeli, Turkey
Kadir Babao
ğ
lu, MD
Department of Paediatrics, Karabük State Hospital,
Karabük, Turkey
Ş
ayegan Güven Filiz, MD
Department of Paediatric Haematology, Kocaeli University
Medical Faculty, Kocaeli, Turkey
Emine Zengin, MD
Nazan Sarper, MD
Department of Paediatric Cardiology, Kocaeli Derince
Education and Research Hospital, Kocaeli Turkey
Gürkan Altun, MD
Department of Paediatric Haematology, Cumhuriyet
University Medical Faculty, Sivas, Turkey
Suar Çakı Kılıç, MD